Together with the positive correlations of DUB3 with KLF4 in human HCC tissue samples and overall survival in HCC patients, our findings suggest that activating the DUB3/KLF4 loop may prevent tumor growth and chemoresistance in HCC. The gene discussed is USP17L2; the disease is neoplasm.